Printer Friendly

Educational Tools

dotted line

With health care costs increasing every year, these statistics are undoubtedly top-of-mind for employers and group administrators. But you get the picture. For those of us with health coverage, what we pay out-of-pocket can mask the true cost of health care.

RegenceRx is committed to providing educational tools for our members and health care partners. When health care choices are made, we want our partners to have the information they need to make decisions that will serve them well. Some of those tools include:

  • ConsumerRx Summaries – member-friendly information about medication choices


  • Generic Medications – myths and facts about generics and how they can help control rising health care costs


  • Formulary Decisions
    Have you ever wondered why some drugs make the RegenceRx formulary and others don’t? If a medication you’re taking isn’t on our formulary, we bet you have wondered.

  • Forms & Training – marketing pieces, presentations and frequently requested forms

We have found that those employer groups willing to help educate their employees are most successful in reducing their prescription costs. Even asking employees to review their medical bills for accuracy and ask about any costs they don't understand has a huge impact.

These simple steps will help keep health care affordable for all of us and build a healthy future.

Did you know?

  • In 2001, 50 drugs (out of almost 9,500) accounted for 62.3% of the $22.5 billion increase in retail prescription spending. 1


  • Prescription drug spending jumped 15.3% in 2002, accounting for 16% of the overall health cost increase. 2


  • Manufacturers spent $25.3 billion for advertising in 2003. Direct-to-consumer advertising was over eight times greater in 2003 than in 1995. 3

Sources:
1 NIHCM Foundation, "Prescription Drug Expenditures in 2001: Another Year of Escalating Costs"
2 Wall Street Journal, “ U.S. Health-Care Spending Rose 9.3% in 2002”, January 9, 2004
3 Kaiser Family Foundation, “Prescription Drug Trends”, October, 2004